Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Axogen, Inc.

AXGN Clue Score44
United States Fiscal year ends December CIK 0000805928 Results filed 28 Oct 2026

What the insiders did Net selling

By person

33 insiders · 250 transactions
4.0×

Michael Dale holds only 4.0 times base salary in stock. $3.16M of shares against $775.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Dale last reported holding, valued at $49.70, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
EW Healthcare Partners, L.P. entity
10% owner
—
$22.70M (1)
−$22.70M
3,711,111
6.90%
$184.43M
−23.7%
Guido J Neels
Director
$61.10K (1)
$22.74M (2)
−$22.68M
3,457,854
6.43%
$171.84M
−23.5%
Jamie Mark Grooms
Director
—
$9.19M (13)
−$9.19M
19,065
0.0355%
$947.47K
−94.3%
Gregory Gene Freitag
Director
—
$4.15M (15)
−$4.15M
283,498
0.5273%
$14.09M
+429.5%
Marc A Began
EVP & General Counsel
—
$3.88M (3) scheduled
−$3.88M
50,135
0.0933%
$2.49M
—
William P. Mr. Burke
Director
$65.60K (1)
$2.86M (14) scheduled
−$2.80M
14,250
0.0265%
$708.18K
—
Kathy Johnson Weiler
Director
—
$2.78M (6) scheduled
−$2.78M
0
0.0000%
$0.00
—
Michael D Dale
Chief Executive Officer
—
$2.67M (2)
−$2.67M
63,537
0.1182%
$3.16M
—
Karen L. Zaderej
CEO
$1.01M (1)
$3.48M (13)
−$2.46M
1,143,788
2.13%
$56.84M
+442.6%
Peter J Mariani
EVP & Chief Financial Officer
—
$2.23M (16) scheduled
−$2.23M
63,603
0.1183%
$3.16M
+687.4%
John Johnson
Director
—
$1.91M (6) scheduled
−$1.91M
14,150
0.0263%
$703.21K
—
Amy McBride Wendell
Director
$347.94K (3)
$2.14M (7) scheduled
−$1.79M
107,976
0.2008%
$5.37M
+709.8%
Joseph A. Tyndall
Director
—
$1.49M (7) scheduled
−$1.49M
10,650
0.0198%
$529.27K
+321.8%
Michael Patrick Donovan
VP Operations
—
$1.15M (12)
−$1.15M
54,250
0.1009%
$2.70M
—
Erick Wayne DeVinney
Chief Innovation Officer
—
$1.11M (9)
−$1.11M
262,781
0.4888%
$13.06M
+2,322%
Lindsey Marie Hartley
CFO
—
$942.20K (5) scheduled
−$942.20K
65,146
0.1212%
$3.24M
+182.7%
Paul Thomas
Director
—
$633.71K (1)
−$633.71K
32,395
0.0603%
$1.61M
—
David K Hansen
VP Finance & Treasurer
—
$452.60K (1)
−$452.60K
25,588
0.0476%
$1.27M
+149.4%
Shawn F McCarrey
SVP Sales
—
$434.70K (1)
−$434.70K
82,921
0.1542%
$4.12M
+141.0%
Jens Kemp
Chief Marketing Officer
—
$428.29K (2)
−$428.29K
72,451
0.1348%
$3.60M
+125.6%
Robert James Rudelius
Director
—
$290.57K (1)
−$290.57K
48,183
0.0896%
$2.39M
+107.0%
Quentin S. Blackford
Director
$217.67K (3)
—
+$217.67K
27,335
0.0508%
$1.36M
—
Doris Quackenbush
Sales VP
—
$168.72K (1)
−$168.72K
92,416
0.1719%
$4.59M
−4.0%
Isabelle Billet
Chief Strategy and BD Officer
$85.14K (13)
$11.56K (1)
+$73.58K
25,065
0.0466%
$1.25M
+563.1%
Angelo Scopelianos
Chief R&D Officer
—
$62.94K (4) scheduled
−$62.94K
57,994
0.1079%
$2.88M
+658.9%
Mark Stephen Gold
Director
$52.39K (6)
—
+$52.39K
601,741
1.12%
$29.90M
−5.9%
Alan M Levine
Director
—
$43.21K (1)
−$43.21K
50,893
0.0947%
$2.53M
—
Maria D. Martinez
Chief Human Resources Officer
$30.26K (1)
$60.11K (2)
−$29.85K
30,476
0.0567%
$1.51M
—
Mark Louis Friedman
VP Regulatory Affairs & Policy
—
$11.67K (2)
−$11.67K
24,343
0.0453%
$1.21M
+105.0%
Nir Naor
CFO
—
—
—
260,868
0.4852%
$12.96M
—
Bradley Ottinger
General Counsel and CCO
—
—
—
23,627
0.0439%
$1.17M
+468.2%
Eric Sandberg
Chief Commercial Officer
—
—
—
16,081
0.0299%
$799.18K
—
Jon S. Gingrich
Chief Commercial Officer
—
—
—
4,190
0.0078%
$208.23K
+150.4%